Podcast
ASCO Daily News
Hosted by American Society of Clinical Oncology (ASCO) · EN
The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.
35episodes
Episodes
Newest firstAll episodes
Immunotherapy Highlights From ASCO26: Cellular Therapy, Melanoma, and Skin Cancers
2d ago00:29:43Tap to summarizeDr. Pauline Funchain and Dr. Allison Betof discuss practice-changing and paradigm-shifting abstracts in melanoma, Merkel cell carcinoma, and cellular therapies that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT
Transcribe →GI Cancer Highlights From ASCO26: RASolute-302, BREAKWATER, and More
3d ago00:22:46Tap to summarizeDr. Nilo Azad and Dr. Aparna Parikh discuss high-impact studies in gastrointestinal cancers and other novel treatment approaches that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT
Transcribe →Hematologic Cancer Highlights From ASCO26: MajesTEC-9, frontMIND, and More
1w ago00:25:05Tap to summarizeDr. Marc Braunstein and Dr. Adam Kittai highlight top research on hematologic malignancies from the 2026 ASCO Annual Meeting, including studies on lymphoid malignancies, multiple myeloma, and plasma cell disorders. LINK TO FULL TRANSCRIPT
Transcribe →Lung Cancer Highlights From ASCO26: HARMONi-6, LIBRETTO-436, and More
1w ago00:22:54Tap to summarizeDr. Christine Lovly and Dr. Vamsi Velcheti discuss practice-changing lung cancer data presented at the 2026 ASCO Annual Meeting, including key studies on squamous cell lung cancer, NSCLC, and SCLC. LINK TO FULL TRANSCRIPT
Transcribe →Day 5: Top Takeaways From ASCO26
3w ago00:09:35Tap to summarizeDr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia in myelofibrosis, advances in RAS-mutated mCRC, novel therapies for AML, and a potentially practice-changing trial in TNBC. LINK TO FULL TRANSCRIPT
Transcribe →Day 4: Top Takeaways From ASCO26
3w ago00:08:45Tap to summarizeDr. Monty Pal shares highlights from Day 4 of the 2026 ASCO Annual Meeting, including a much-anticipated study in hepatocellular carcinoma, new data in non–small cell lung cancer, and a key update in the treatment of Merkel cell carcinoma. LINK TO TRANSCRIPT
Transcribe →Day 3: Top Takeaways From ASCO26
4w ago00:08:54Tap to summarizeDr. Monty Pal shares highlights from Day 3 of the 2026 ASCO Annual Meeting, including new research for the treatment of advanced CRC and mCRPC, TIL cell therapy in advanced non-uveal melanoma, and an ultra-low dose immunotherapy trial in head and neck squamous cell carcinoma. LINK TO FULL TRANSCRIPT
Transcribe →Day 2: Top Takeaways From ASCO26
4w ago00:08:19Tap to summarizeDr. Monty Pal shares highlights from Day 2 of the 2026 ASCO Annual Meeting, including a practice-changing trial in renal cell carcinoma, advances in ER-positive, HER2-negative early breast cancer, and the use of olanzapine as an effective steroid-sparing alternative for chemo-induced nausea and vomiting in pediatric cancer. LINK TO FULL TRANSCRIPT
Transcribe →Day 1: Top Takeaways From ASCO26
4w ago00:07:54Tap to summarizeIn the first episode of a special daily series during the 2026 ASCO Annual Meeting, Dr. Monty Pal discusses 3 abstracts, including a follow-up on the EV-302 study in urothelial carcinoma, a potential new treatment option for patients with PD-L1-positive advanced non–small cell lung cancer, and a novel psychosocial digital application that improves fatigue and distress in patients with multiple myeloma. LINK TO FULL TRANSCRIPT
Transcribe →ASCO26 Preview: Novel Therapies and Innovations in Cancer Care
May 2100:23:54Tap to summarizeDr. Monty Pal and Dr. Jo Chien preview new research, hot topics, and emerging innovations in oncology that will be presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT
Transcribe →